PL405046A1 - Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie - Google Patents
Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanieInfo
- Publication number
- PL405046A1 PL405046A1 PL405046A PL40504613A PL405046A1 PL 405046 A1 PL405046 A1 PL 405046A1 PL 405046 A PL405046 A PL 405046A PL 40504613 A PL40504613 A PL 40504613A PL 405046 A1 PL405046 A1 PL 405046A1
- Authority
- PL
- Poland
- Prior art keywords
- mmp
- activity
- biosensor
- fret
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Wynalazek dotyczy genetycznie zakodowanego, wykorzystującego zjawisko FRET biosensora do monitorowania aktywności metaloproteazy macierzy zewnątrzkomórkowej 9 (MMP-9). MMP-9 jest zewnątrzkomórkową endopeptydazą zaangażowaną zarówno w procesy fizjologiczne i patologiczne. Zakotwiczony w błonie komórkowej, genetycznie zakodowany, wykorzystujący zjawisko FRET, biosensor pozwala na badanie aktywności proteolitycznej MMP-9 z wysoką rozdzielczością czasowo-przestrzenną bezpośrednio w miejscu aktywności MMP-9 na komórce. Funkcjonalność biosensora, zarówno in vitro i in vivo w żywych komórkach została wykazana przy pomocy analizy ratiometrycznej cięcia biosensora przez oczyszczoną auto-aktywującą zmutowaną MMP-9.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL405046A PL405046A1 (pl) | 2013-08-12 | 2013-08-12 | Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie |
US14/911,821 US9914955B2 (en) | 2013-08-12 | 2014-08-12 | Genetically encoded FRET-based MMP-9 activity biosensor and use thereof |
JP2016533982A JP2016526926A (ja) | 2013-08-12 | 2014-08-12 | 遺伝子的にコードしたfretベースのmmp−9活性バイオセンサおよびその使用 |
EP14789607.0A EP3033621A2 (en) | 2013-08-12 | 2014-08-12 | Genetically encoded fret-based mmp-9 activity biosensor and use thereof |
CN201480047715.0A CN105593686A (zh) | 2013-08-12 | 2014-08-12 | 遗传编码的基于fret的mmp-9活性生物传感器及其用途 |
PCT/IB2014/063883 WO2015022646A2 (en) | 2013-08-12 | 2014-08-12 | Genetically encoded fret-based mmp-9 activity biosensor and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL405046A PL405046A1 (pl) | 2013-08-12 | 2013-08-12 | Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie |
Publications (1)
Publication Number | Publication Date |
---|---|
PL405046A1 true PL405046A1 (pl) | 2015-02-16 |
Family
ID=51795665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL405046A PL405046A1 (pl) | 2013-08-12 | 2013-08-12 | Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie |
Country Status (6)
Country | Link |
---|---|
US (1) | US9914955B2 (pl) |
EP (1) | EP3033621A2 (pl) |
JP (1) | JP2016526926A (pl) |
CN (1) | CN105593686A (pl) |
PL (1) | PL405046A1 (pl) |
WO (1) | WO2015022646A2 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105572088A (zh) * | 2016-01-14 | 2016-05-11 | 刘伟 | 一种检测mmp-9功能的fret生物传感器及其构建方法与应用 |
KR102018249B1 (ko) * | 2017-04-04 | 2019-09-10 | 한양대학교 산학협력단 | 프로테아제 활성 분석용 프로브 및 이를 이용한 분석 방법 |
CN112567245A (zh) * | 2018-08-28 | 2021-03-26 | Jl美迪乐博斯公司 | 检测目标物质的方法和试剂盒 |
KR102659088B1 (ko) * | 2019-11-18 | 2024-04-24 | 서울대학교병원 | Mmp 센서 기반의 실시간 구형 구축 모니터링과 치료가 가능한 유방 재건용 조직 확장기 및 이와 연계된 환자 정보 시스템 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7935801B2 (en) * | 2005-05-20 | 2011-05-03 | The Governors Of The University Of Alberta | Teal fluorescent proteins |
NO20053354D0 (no) * | 2005-07-11 | 2005-07-11 | Amersham Health As | Optical imaging contrast agent. |
EP2054514A4 (en) * | 2006-08-04 | 2009-11-04 | Univ Georgia State Res Found | ENZYME SENSORS, METHODS OF PREPARATION AND USE OF SUCH SENSORS, AND METHODS OF DETECTING PROTEASE ACTIVITY |
CN100557031C (zh) * | 2006-12-27 | 2009-11-04 | 华中科技大学 | 检测基质金属蛋白酶活性的多核苷酸序列 |
CN101932936B (zh) * | 2007-09-14 | 2016-04-27 | 拜奥麦迪逊公司 | 利用切割序列和间隔子的共振能量转移测定 |
WO2010017203A1 (en) * | 2008-08-04 | 2010-02-11 | The Board Of Trustees Of The University Of Illinois | Fret-based membrane-type 1 matrix metalloproteinase biosensor and methods for using the same |
JP2012177549A (ja) * | 2009-06-24 | 2012-09-13 | Hokkaido Univ | 蛍光温度プローブおよびそれを用いた温度測定装置 |
JP6124150B2 (ja) * | 2011-07-29 | 2017-05-10 | アベラス バイオサイエンシーズ,インク. | 選択的な送達分子及び使用方法 |
-
2013
- 2013-08-12 PL PL405046A patent/PL405046A1/pl unknown
-
2014
- 2014-08-12 EP EP14789607.0A patent/EP3033621A2/en not_active Withdrawn
- 2014-08-12 JP JP2016533982A patent/JP2016526926A/ja active Pending
- 2014-08-12 WO PCT/IB2014/063883 patent/WO2015022646A2/en active Application Filing
- 2014-08-12 CN CN201480047715.0A patent/CN105593686A/zh active Pending
- 2014-08-12 US US14/911,821 patent/US9914955B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN105593686A (zh) | 2016-05-18 |
WO2015022646A4 (en) | 2015-06-25 |
WO2015022646A2 (en) | 2015-02-19 |
WO2015022646A3 (en) | 2015-05-07 |
US20160194681A1 (en) | 2016-07-07 |
US9914955B2 (en) | 2018-03-13 |
JP2016526926A (ja) | 2016-09-08 |
EP3033621A2 (en) | 2016-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL405046A1 (pl) | Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie | |
RU2012105922A (ru) | Дифференцирование человеческих эмбриональных стволовых клеток | |
ATE494834T1 (de) | Säuglingsmonitor | |
BR112013014003A2 (pt) | Métodos de redução de produção de sebo na pele | |
EA201071324A1 (ru) | Система и способы измерения профилей биомаркеров | |
CR20130657A (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
UY29777A1 (es) | Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión. | |
BR112012010252A2 (pt) | variantes de glicosilação de anticorpo | |
MA38042B2 (fr) | Méthylglyoxal en tant que marqueur du cancer | |
DE60231814D1 (de) | Diagnostische marker für ischämie und mortalitätsrisiken | |
ATE520032T1 (de) | Differentielle cytokinexpression bei einer menschlichen krebserkrankung | |
BR112014000113A2 (pt) | sistema e método para prever a viabilidade de um tecido corporal em um paciente e dispositivo de medição para medir a pressão de perfusão local em um tecido corporal de um paciente | |
WO2007084397A3 (en) | Processing of slpi by chymase | |
CO6430490A2 (es) | Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral | |
BR112014029808A2 (pt) | método para testar o efeito de uma etapa de produção ou etapas de produção ou a eficácia de uma etapa de purificação ou etapas de purificação na presença ou na natureza de moléculas pró-inflamatórias em polímeros de glicose ou hidrolisados dos mesmos; e método otimizado para produzir ou purificar polímeros de glicose ou hidrolisados dos mesmos | |
BR112013031431A2 (pt) | método para o diagnóstico da doença de gaucher | |
SE0801748L (sv) | Anordning vid provtagningsnålar | |
AR085164A1 (es) | Metodos para el analisis de la placa | |
TR200802195A2 (tr) | Yüzeyde zenginleştirilmiş raman saçılmasına dayalı doku farklılaştırma yöntemi. | |
PE20142280A1 (es) | Metodo de tamizaje de la neurogenesis y el sistema que utiliza las celulas madre derivadas del tejido adiposo | |
RU2009126387A (ru) | Способ изучения перцептивных звеньев в структуре функциональных систем, реализующих процессы внимания | |
Laflamme et al. | Study of the bidirectional sensing characteristic of a thin film strain gauge for monitoring of wind turbine blades | |
Bonifacio et al. | Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. | |
RU2011113334A (ru) | Способ индивидуального выбора лекарственных препаратов при терапии артериальной гипертензии | |
RU2011117771A (ru) | Способ постановки диагноза у больного в критическом состоянии |